XIENCE Sierra™ 1550275-08Recalls & reported problems
Abbott Vascular Inc. · XIENCE Sierra™ Everolimus Eluting Coronary Stent System 2.75 mm x 08 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE Sierra (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648227158), received between Dec 19, 2019 and Apr 23, 2021 — classified as 3 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Angina2
- Stenosis2
- High Blood Pressure/ Hypertension1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryApr 23, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2019, THE PATIENT PRESENTED WITH A SEVERELY CALCIFIED, PROXIMAL CIRCUMFLEX (CX) CORONARY ARTERY WITH A CHRONIC TOTAL OCCLUSION AND 70% STENOSED LESION. PRE-DILATATION WAS PERFORMED AND A 2.75X8MM XIENCE SIERRA STENT (1550275-08, 8092641) WAS IMPLANTED IN THE PROXIMAL CX, WITHOUT A DEVICE ISSUE REPORTED. FOLLOWING, PRE-DILATATION WAS PERFORMED ON THE 2ND OBTUSE MARGINAL (OM) CORONARY ARTERY, 95% STENOSED LESION AND A 2.75X8MM XIENCE SIERRA STENT (1550250-08, 9020541) WAS IMPLANTED WITHOUT A DEVICE ISSUE REPORTED. ON (B)(6) 2021, THE PATIENT WAS HOSPITALIZED FOR CHEST PAIN. PER IMAGING, THE PROXIMAL CX WAS 90% STENOSED. AS TREATMENT, ANOTHER DRUG-ELUTING STENT WAS PLACED IN THE PROXIMAL CX. IN ADDITION, ANOTHER STENT WAS ALSO IMPLANTED IN THE 80% STENOSED PROXIMAL RIGHT CORONARY ARTERY LESION. PER PHYSICIAN, THERE WAS NO DEVICE MALFUNCTION AND THE EVENT WAS UNRELATED TO THE XIENCE DEVICE. THE EVENT RESOLVED WITHOUT SEQUELA. NO ADDITIONAL INFORMATION WAS PROVIDED REGARDING THIS ISSUE.
Patient problems: Angina; Stenosis
MAUDE report 11716780 ↗InjuryJun 18, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2020, A 2.75X08MM AND 2.75X18MM XIENCE SIERRA STENT WERE IMPLANTED WITHOUT A DEVICE ISSUE NOTED. ON (B)(6) 2020, THE PATIENT WAS ADMITTED TO THE HOSPITAL DUE TO HYPERTENSION. THE PATIENT WAS DISCHARGED HOME 4 DAYS LATER. THE DEVICE RELATIONSHIP TO THE EVENT IS UNKNOWN. NO ADDITIONAL INFORMATION WAS PROVIDED REGARDING THIS ISSUE.
Patient problems: High Blood Pressure/ Hypertension
MAUDE report 10169438 ↗InjuryDec 19, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
PATIENT ID (B)(6). IT WAS REPORTED THAT ON (B)(6) 2019, THE PATIENT UNDERWENT A CORONARY PROCEDURE, TREATING A TARGET LESION IN THE CIRCUMFLEX (CX) ARTERY. A 2.75 X 8 MM XIENCE SIERRA STENT WAS IMPLANTED. ON (B)(6) 2019, THE PATIENT WAS SEEN FOR A FOLLOW UP VISIT AND REPORTED ANGINA. THE PATIENT¿S IMDUR MEDICATION DOSAGE WAS INCREASED. THE PATIENT CONDITION CONTINUES. NO ADDITIONAL INTERVENTION WAS PERFORMED. ON (B)(6) 2019, THE PATIENT UNDERWENT CORONARY ANGIOGRAPHY, DUE TO ONGOING CHEST PAIN. IN-STENT RESTENOSIS WAS NOTED IN THE TARGET LESION, AS WELL AS THE LEFT MAIN ARTERY. SURGICAL CONSULT WAS OBTAINED AND THE PATIENT UNDERWENT CORONARY ARTERY BYPASS GRAFT (CABG) ON (B)(6) 2019. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina; Stenosis
MAUDE report 9492825 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page